Table 4.

Lipid-Lowering agents in the treatment of nonalcoholic fatty liver disease.

First author/date of study	n	Drug	Treatment duration (months)	Transaminase reduction	Histologie improvement
Laurin et al. (1996)	16	Clofibrate	12	No	No
Basaranoglu et al. (1999)	46	Gemfibrozil	1	Yes	No data
Saibara et al. (1999)	2	Bezafibrate	10	No data	Yes; steatosis
Horlander et al. (2001)	7	Atorvastatin	12	Yes	Yes; only inflammation improved
Kiyici et al. (2003)	27	Atorvastatin	6	Yes	Yes; steatosis
Rallidis et al. (2004)	5	Pravastatin	6	Yes	Yes; steatosis and inflammation better
Antonopoulos et al. (2006)	23	Rosuvastatin	8	Yes	No data
Merat et al. (2007)	10	Probucol	12	Yes	Yes; steatosis and inflammation better
Fernandez-Miranda et al. (2008)	16	Fenofibrate	12	Yes	Yes; reduced hepatocellular ballooning